Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data

Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing

(2010) P Lenzini et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters

(2010) Christof Geisen et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements

(2009) Janne Cadamuro et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design

(2009) Rianne MF van Schie et al.   PHARMACOGENOMICS

The largest prospective warfarin-treated cohort supports genetic forecasting

(2008) M. Wadelius et al.   BLOOD

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

(2008) BF Gage et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practice

(2008) Laurent Becquemont   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Improvement in the regulation of the vitamin K antagonist acenocoumarol after a standard initial dose regimen: prospective validation of a prescription model

(2008) Johanna H. H. Van Geest-Daalderop et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

VKORC1andCYP2C9allelic variants influence acenocoumarol dose requirements in Greek patients

(2008) Christos N Markatos et al.   PHARMACOGENOMICS